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Abstract
Seroadaptation is defined as the practice of modifying sexual behavior based on one’s own
HIV serostatus, the perceived HIV serostatus of sexual partners, and differences in risk of
HIV transmission by sexual acts. Because this definition implies intent, we use the term “ser-
oprotection” to describe HIV negative participants reporting condomless anal sex (CAS) ei-
ther exclusively with seronegative partners, or only as the insertive partner with HIV positive
or unknown serostatus partners. Little is known about seroprotection in Black men who have
sex with men (MSM). We evaluated the independent association of seroprotection and HIV
acquisition among the 1144 HIV-negative Black MSM enrolled in HPTN 061 using Cox mod-
els; we stratified by city of enrollment, and controlled for number of partners, age, and drug
use. Behaviors reported at 0, 6, and 12 months were assigned to three mutually exclusive
categories: (1) No CAS; (2) Seroprotection; and (3) CAS without seroprotection. In 2,861 six-
month intervals; 28 HIV seroconversions occurred. No CAS was reported at 33.3% of visits,
seroprotection at 46.6% of visits, and CAS without seroprotection at 20.1% of visits. The se-
roconversion rate per 100 person-years for no CAS was 0.98 (95% CI: 0.27, 2.51), compared
with 2.39 (95% CI: 1.03, 4.71) and 13.33 (95% CI: 7.62, 21.66) for seroprotection and CAS
without seroprotection, respectively. Compared to CAS without seroprotection, intervals
without CAS were associated with an 87% reduction (aHR: 0.13, 95%CI: 0.03–0.46) in HIV
acquisition and intervals with seroprotection with a 78% reduction (aHR: 0.22, 95% CI: 0.09–
0.57). No CAS is the safest behavior to prevent HIV acquisition. Seroprotective behaviors
significantly reduced risk, but HIV incidence was still>2/100 person-years, suggesting that
additional strategies, such as pre-exposure prophylaxis, are warranted for this population.
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Introduction
Black men who have sex with men (MSM) are disproportionately affected by the HIV epidemic
in the United States (US). Approximately one quarter of all new HIV infections in the US
occur among Black MSM [1]. Moreover, the Centers for Disease Control and Prevention
(CDC) reports a 48% increase in HIV incidence among young black MSM between 2006 and
2009 [2]. Due to the disproportionate impact of HIV on Black MSM, HIV prevention has be-
come a key focus area in addressing HIV-related health disparities among this group.
Seroadaptation has traditionally been defined as the practice of modifying sexual behaviors
based on one’s own HIV serostatus, the perceived HIV serostatus of a sexual partner, and differ-
ences in risk of HIV transmission by sexual acts [3]. For example, seroadaptation in HIV-
negative MSM can include: serosorting where condomless anal sex (CAS) is limited to a partner
or partners believed to be HIV negative; being an exclusive top where all CAS is in the insertive
position; and seropositioning or strategic positioning where CAS is in the receptive position with
negative partners, but only in the insertive position with potentially serodiscordant partners.
These behaviors have been widely reported among MSM and are presumably used to reduce
risk of HIV acquisition and transmission [4–7]. Although seroadaptation implies intentional al-
tering of behaviors based on partner serostatus, most longitudinal studies reporting on sexual
behaviors have not asked participants about intent, but simply categorize based on reported be-
haviors. Therefore, the terms encompassed by seroadaptation are more accurately defined as
“seroprotection” or categorizing patterns of sexual behavior (e.g., HIV negative participants re-
porting CAS either exclusively with seronegative partners, or only as the insertive partner with
HIV positive or unknown serostatus partners), whether intentional or not. While not recom-
mended by the CDC as an HIV prevention strategy among HIV-negative MSM, several studies
have demonstrated that seroprotection, while posing a higher risk than consistent condom use,
carry a lower risk of HIV acquisition than having CAS without regard to partner HIV status or
sexual position [8–11]. However, many of these studies were comprised of predominantly
White samples of MSM that enrolled a small proportion of MSM of color. Given the underrep-
resentation of Black MSM in most of these studies and the substantially higher rates of HIV in-
fection in this population, studies focused on Black MSM are needed.
Results of previous studies examining seroprotection among Black MSM have varied. One
study examining racial differences in seroprotection found that Black MSMmay be less likely
to report engaging in any seroprotection, and may be less likely to believe that seroprotection is
an effective HIV prevention strategy [7]. The Brothers y Hermanos study of Black and Latino
MSM in the US found that among Black MSM, serosorting and strategic positioning were both
associated with a lower risk of HIV infection as compared to CAS regardless of partner status
or sexual position [12]. However, a study of sexually transmitted disease (STD) clinic attendees
from Seattle found serosorting was associated with a lower risk of HIV infection among White
MSM but was not protective among Black MSM [10,13]. Further research on seroprotection
among Black MSM is needed to better understand the frequency of these behaviors and how
these strategies may possibly be used for harm reduction in this population.
HPTN 061 is the largest longitudinal HIV prevention study among Black MSM in the US
and provides the opportunity to understand seroprotection among Black MSM. The objectives
of the current analysis were to examine the prevalence and assess the effectiveness of seropro-
tection among Black MSM in preventing HIV acquisition.
Methods
HPTN 061, a study designed to evaluate the feasibility and acceptability of a multi-component
HIV prevention intervention among Black MSM, recruited from July 2009 to October 2010.
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Participants were recruited through community outreach or as sexual network partners referred
by index participants in Atlanta, Boston, Los Angeles, New York City, San Francisco, andWash-
ington DC. The institutional review boards (IRB) at all participating institutions approved the
HPTN 061 study [14]. Men were eligible to participate in the study if they self-identified as a
man or male at birth and as Black, African American, Caribbean Black, or multiethnic Black,
were at least 18 years old, reported at least one instance of CAS with a man in the past six
months, and resided in the metropolitan area and had no plans to move during the study. If
men were enrolled in any other HIV interventional research study, had been a participant in an
HIV vaccine trial or were a community-recruited participant in a category that had reached its
enrollment cap, they were ineligible for the study. Data collection at enrollment included inter-
viewer-collected demographic and social and sexual network information. To minimize social
desirability, audio computer-assisted self-interview (ACASI) was utilized to collect self-reported
data on HIV testing history and sexual risk behavior. This analysis was limited to participants
who were HIV-negative, biological male, and reported behavioral characteristics during the
study time period. The methods of the study have been described in detail elsewhere [14].
Measures
In HPTN 061, behaviors reported on ACASI in the prior six months were divided into three
mutually exclusive categories:
1. No CAS: intervals during which participants reported no sex of any kind, only oral sex, or
consistent condom use during all anal sex episodes, regardless of partner serostatus.
2. Seroprotection: intervals in which participants reported some CAS, but that in every case
during this interval, the CAS was with a partner or partners believed to be HIV negative
(serosorting), was in the insertive position either with all partners (exclusive top) or only
with potentially serodiscordant partners (seropositioning or strategic positioning).
3. CAS without seroprotection: all other intervals, during which participants reported some
CAS without potentially protective seroprotection and engaged in receptive anal intercourse
with an HIV-positive or unknown-status partner.
The above categories were adapted from previous work [5, 11]. As noted in the introduc-
tion, these sexual behaviors do not imply any intentional practice.
Statistical Analysis
Demographic and baseline characteristics were summarized by frequency distributions (for cat-
egorical variables) or median and interquartile range (for continuous variables). Multinomial lo-
gistic regression was used to estimate the independent associations of covariates with the
repeated sexual behavior measures, contrasting category 2 (Seroprotection) and category
3 (CAS without seroprotection) with category 1 (No CAS), the least risky behavior pattern. Ro-
bust standard errors were used to account for within-subjects correlation of the repeated out-
comes. To assess the association between the various sexual risk categories and HIV infection,
we used Cox models with the baseline hazard stratified by city. HIV acquisition was assessed at
each six-month visit. Over the duration of the study, participants could be placed into a different
category at each study interval, based on their reported behaviors in the previous six months.
Seroprotective category was treated as a time-dependent covariate, with results summarized by
relative hazards using category 1 and then category 3 as the reference level. All models were ad-
justed for age at enrollment, number of sexual partners and any methamphetamine, cocaine, or
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amyl nitrite use in the prior six months as time dependent covariates. Data analyses were imple-
mented in Stata Version 12.0 (Stata Corp, College Station, TX) and SAS Version 9.2.
Results
Among the 1144 Black MSM included in this analysis, 1110 completed behavioral data at base-
line. The median age of the sample was 39 years. More than half of the men had a high school
education or less and nearly 40% had an annual household income under $10,000 (Table 1).
Cocaine/crack use was reported by 25% of men which was more common than methamphet-
amine (9%) or amyl nitrite (9%) use in the past six months.
In multivariate modeling controlled by city, those reporting seroprotection were younger,
more likely to have attended some college, and report a higher number of male partners com-
pared to those reporting no CAS (Table 2). Those reporting CAS without seroprotection were
more likely to be younger, have a higher number of partners and use methamphetamines or
amyl nitrite as compared to those reporting no CAS. All 1144 participants were included in
multivariate modeling as they reported behavioral characteristics at subsequent time points.
Over the 12-month follow-up period, 28 of the 1144 participants HIV seroconverted
(Table 3). Of 2,861 six-month intervals, 33.3% of the visits were categorized as no CAS (Cate-
gory 1), 46.6% as seroprotection (Category 2), and 20.1% as CAS without seroprotection (Cate-
gory 3). We built two multivariate models, each stratified by city and adjusted for age at
enrollment, number of sexual partners and any methamphetamine, cocaine or amyl nitrite use.
The seroconversion rate per 100 person-years for no CAS was 0.98 (95% CI: 0.27, 2.51) while
the seroconversion rate for seroprotection and CAS without seroprotection was 2.39 (95% CI:
1.03, 4.71) and 13.33 (95% CI: 7.62, 21.66) respectively. Compared to CAS without seroprotec-
tion, intervals without CAS were associated with an 87% reduction (aHR: 0.13, 95% CI:
0.03–0.46) in HIV acquisition, and intervals with seroprotection with a 78% reduction (aHR:
0.22, 95% CI: 0.09–0.57). When no CAS was used as the reference category, seroprotection was
not significantly associated with risk (aHR 1.78, 95% CI 0.45–6.99).
Discussion
In the largest prospective cohort of Black MSM in the US, we have evaluated the independent
association of progressive levels of sexual risk behaviors with HIV acquisition. In this analysis
of 1144 Black HIV-negative MSM in six US cities, we found that no CAS is the behavior associ-
ated with the lowest HIV acquisition risk. Seroprotection significantly reduced HIV acquisition
as compared to CAS without seroprotection, however, HIV incidence was still>2/100 person-
years, a substantial rate of infection. Our data are consistent with the Brothers y Hermanos
study, a cross-sectional study of Black and Latino men which separately analyzed two kinds of
seroprotection: serosorting and strategic positioning [12]. In their study, the odds for testing
HIV antibody-positive among Black and Latino serosorters were somewhat (but not statistical-
ly significantly) more likely to be HIV positive than men who reported no CAS, but significant-
ly more likely to be HIV negative compared with men reporting CAS without serosorting.
Their study evaluated seropositioning separately and found that it was also associated with a
lower likelihood of being HIV positive as compared to receptive CAS without seropositioning
[12]. In contrast, a recent cross-sectional analysis from a Seattle STD clinic found that MSM re-
porting only HIV negative partners were less likely to be HIV positive than MSM reporting
nonconcordant CAS among White, but not Black MSM [13]. Although the Black MSM in the
Seattle study had lower reported sexual risk and similar testing histories to the White MSM,
they were more likely to test HIV positive which may suggest they were less likely to have accu-
rate information about the serostatus of their partners [13]. The Seattle study results may be
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Table 1. Demographic and behavioral characteristics of HPTN 061 participants by seroprotective behavior at baseline.
Characteristic Total N (%) Category 1: No CAS N
(%)
Category 2: Seroprotection
N (%)
Category 3: CAS without
seroprotection N (%)
Total1 1110 127 654 329
Age
Median 39 41 39 33
25th, 75th %tile 25, 47 27, 48 27, 47 23, 45
Education
Missing 1/1110
(<1%)
0/127 (0%) 0/654 (0%) 1/329 (<1%)
Less than college 585/1110
(53%)
82/127 (65%) 342/654 (52%) 161/329 (49%)
Some college or more 524/1110
(47%)
45/127 (35%) 312/654 (48%) 167/329 (51%)
Annual Income
Missing 11/1110 (1%) 0/127 (0%) 6/654 (1%) 5/329 (2%)
<$10,000 408/1110
(37%)
52/127 (41%) 227/654 (35%) 129/329 (39%)
>$10,000 691/1110
(62%)
75/127 (59%) 421/654 (64%) 195/329 (59%)
Substance use in the past 6
months
Methamphetamine 101/1110
(9%)
8/127 (6%) 51/654 (8%) 42/329 (13%)
Cocaine/Crack 278/1110
(25%)
38/127 (30%) 158/654 (24%) 82/329 (25%)
Amyl Nitrite 105/1110
(9%)
5/127 (4%) 48/654 (7%) 52/329 (16%)
Total male partners
Median 3 2 3 5
25th, 75th %tile 2,6 1, 3 2, 6 3, 8
1 Participants who are HIV negative, biological male and reported seroprotective behaviors at baseline are included in the table. Data on behavioral
characteristics at baseline missing for 34 participants (total cohort N = 1144). CAS—Condomless anal sex
doi:10.1371/journal.pone.0118281.t001
Table 2. Multinomial logistic regression of covariates with sexual behavior (includes all visits)1.
Category 2: Seroprotection (Reference:
Category 1-No CAS)
Category 3: CAS without seroprotection
(Reference: Category 1-No CAS)
Variable RRR 95% CI p-value RRR 95% CI p-value
Age (every 10 years increase) 0.87 0.80, 0.96 0.005 0.69 0.60, 0.79 <0.0001
Education (Ref: No college) 1.27 1.03, 1.55 0.02 1.17 0.87, 1.56 0.29
Income (Ref: < 10,000) 1.22 0.99, 1.51 0.06 0.94 0.70, 1.26 0.67
Number of partners (Ref: < 2 partners) 4.24 3.41, 5.26 <0.0001 11.32 8.58, 14.94 <0.0001
Substance use in the past 6 months
Methamphetamine (Ref: No) 1.24 0.85, 1.79 0.27 1.62 1.02, 2.56 0.04
Cocaine/Crack (Ref: No) 1.05 0.81, 1.34 0.72 1.36 0.94, 1.95 0.10
Amyl Nitrite (Ref: No) 1.17 0.79, 1.74 0.43 2.00 1.26, 3.18 0.003
1controlled by city; CAS-condomless anal sex
doi:10.1371/journal.pone.0118281.t002
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different from ours because of their study focusing on patients in a STD clinic, rather than par-
ticipants volunteering for a longitudinal study; geographic differences (e.g. testing frequency,
proportion unaware of HIV infection) between Seattle and the 6 cities represented in HPTN
061; and a cross-sectional study rather than the longitudinal analysis used in our study.
Some studies have suggested that Black MSM were less likely to report seroprotection com-
pared to MSM from other races/ethnicities. Our study revealed that Black MSM engaged in ser-
oprotection at proportions similar to or higher than other largely White MSM cohorts. A
recent pooled analysis of North American cohorts of predominantly White MSM from vaccine
and behavioral intervention studies from 1995 to 2007 with a large sample (total of 12,277 par-
ticipants; 60,162 six-month intervals with 663 HIV seroconversions) found that no CAS was
reported in 47.4%, seroprotection in 31.8%, and CAS without seroprotection in 20.4% of visits;
our study found proportions of 33.3%, 46.6%, and 20.1% respectively [11]. Our results were
also consistent with the Brothers y Hermanos study in which 42% of Black MSM reported ei-
ther serosorting or strategic positioning.
Several limitations to this study exist. First, our results were obtained using self-reported be-
haviors with ACASI. While ACASI increases the accuracy in the reporting of sexual and sub-
stance abuse behaviors and decreases the social desirability bias, it does not eliminate bias, as
evidenced by the seroconversions in those reporting no CAS. Other explanations for infections
in this group are recall bias, unrecognized condom failure or HIV acquisition through other
HIV risk practice such as oral sex or injection drug use. We did not have power to analyze sero-
protective strategies individually, and were unable to determine which specific behaviors may
have contributed to decreased risk. Finally, the median age of the Black MSM included in this
cohort was 39 at baseline and so it is unclear if these findings are generalizable to young Black
MSM as HIV testing frequency and proportion unaware of infection could be different from
the cohort included in this study.
Because our study found high rates of Black MSM engaging in seroprotection, it will be im-
portant to understand whether Black MSM are intentionally adopting these behaviors as a
harm reduction strategy, and if so, how consistent these behaviors are over time. Concerns
have been expressed about promoting seroprotection for Black MSM because of the potential
for high rates of undiagnosed HIV and high existing prevalence in potential partners [2,15,16].
Although seroprotection could serve as a harm reduction strategy, men in the seroprotection
group had an HIV incidence of greater than 2/100 person-years, suggesting such behaviors
may benefit from additional interventions, such as pre-exposure prophylaxis [17]. In addition,
the effectiveness of seroprotection relies on accurate knowledge and disclosure of serostatus;
unfortunately, 46% of HIV seropositive Black MSM are unaware of their status [16]. Sexually
Table 3. Adjusted relative hazards ratio of HIV seroconversion among Black MSM in HPTN 061.
Risk category Visits N (%) HIV SC
(N)
Seroconversion Rate (per 100 person-
years) (95%CI)
Adjusted HR1 (Model
1) (95% CI)
Adjusted HR1 (Model
2) (95% CI)
Category 1-No CAS 953
(33.31%)
4 0.98 (0.27, 2.51) Reference 0.13 (0.03–0.46)
Category 2-Seroprotection 1332
(46.56%)
8 2.39 (1.03, 4.71) 1.78 (0.45–6.99) 0.22 (0.09–0.57)
Category 3-CAS without
seroprotection
576
(20.13%)
16 13.33 (7.62, 21.66) 8.03 (2.17–29.69) Reference
1Adjusted for age, number of sexual partners, and any methamphetamine, cocaine and amyl nitrite use in the last six months, stratiﬁed by city. CAS-
condomless anal sex; SC-Seroconversion
doi:10.1371/journal.pone.0118281.t003
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transmitted infections also increase susceptibility to HIV acquisition, and STI rates are noted
to be high among Black MSM [18–20]. Through a combination of PrEP, HIV and STI testing,
disclosure interventions, and possibly seroprotection, we may be able to achieve substantial re-
ductions in HIV incidence among Black MSM.
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